SCHEMBL162387

SCHEMBL162387

NC(=O)CP(=O)(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butane SCHEMBL11185393 0.89 MEN1 (0.43)
SCHEMBL13733829 0.75
SCHEMBL9862949 0.75
SCHEMBL27874570 0.73
SCHEMBL27291042 0.73
SCHEMBL28228676 0.72 MEN1 (0.59)
SCHEMBL492088 0.71 PGK1 (0.50)
SCHEMBL13733832 0.71
SCHEMBL4625328 0.71
SCHEMBL3398572 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 312 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025043316-A1 PROCESS FOR OBTAINING ANTI-INFLAMMATORY COMPOUNDS, SAID COMPOUNDS, PHARMACEUTICAL COMPOSITION AND USE OF SAID COMPOUNDS AND OF THE PHARMACEUTICAL COMPOSITION UNIVERSIDADE ESTADUAL DE CAMPINAS (BR) 2025-03-06 WO claimed
US-20140249105-A1 NOVEL CERAMIDE ANALOGUES, PROCESSES FOR PREPARING SAME AND USES THEREOF DIVERCHIM (FR) 2014-09-04 US claimed
EP-2736876-A1 NOVEL CERAMIDE ANALOGUES, PROCESSES FOR PREPARING SAME AND USES THEREOF Diverchim (FR) 2014-06-04 EP claimed
CN-103764620-A Novel ceramide analogues, processes for preparing same and uses thereof DIVERCHIM 2014-04-30 CN claimed
WO-2013014354-A1 NOVEL CERAMIDE ANALOGUES, PROCESSES FOR PREPARING SAME AND USES THEREOF DIVERCHIM (FR) 2013-01-31 WO claimed
EP-2212328-A2 NOVEL COMPOUNDS OF REVERSE TURN MIMETICS AND THE USE THEREOF (2) Choongwae Pharma Corporation (KR) 2010-08-04 EP claimed
EP-2212329-A2 NOVEL COMPOUNDS OF REVERSE TURN MIMETICS AND THE USE THEREOF (1) Choongwae Pharma Corporation (KR) 2010-08-04 EP claimed
EP-2212330-A2 NOVEL COMPOUNDS OF REVERSE TURN MIMETICS AND THE USE THEREOF (3) Choongwae Pharma Corporation (KR) 2010-08-04 EP claimed
WO-2009051397-A2 NOVEL COMPOUNDS OF REVERSE TURN MIMETICS AND THE USE THEREOF (3) CHOONGWAE PHARMA CORPORATION (KR) 2009-04-23 WO claimed
WO-2009051398-A2 NOVEL COMPOUNDS OF REVERSE TURN MIMETICS AND THE USE THEREOF (2) CHOONGWAE PHARMA CORPORATION (KR) 2009-04-23 WO claimed
WO-2009051399-A2 NOVEL COMPOUNDS OF REVERSE TURN MIMETICS AND THE USE THEREOF (1) CHOONGWAE PHARMA CORPORATION (KR) 2009-04-23 WO claimed
EP-1019418-B1 INOSITOL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM BIONERIS AB (SE) 2004-04-28 EP claimed
EP-0281980-B1 PROCESS FOR THE PREPARATION OF AMINOCARBONYLMETHANACIDES OF PHOSPHORUS HOECHST AKTIENGESELLSCHAFT (DE) 1991-09-18 EP claimed
US-4396556-A REACTING A 2-HALOACETAMIDE WITH A PHOSPHONATE, PHOSPHINATE, OR PHOSPHINE OXIDE IN A TWO-PHASE LIQUID SYSTEM OCCIDENTAL RESEARCH CORPORATION (US) 1983-08-02 US claimed
US-20260146249-A1 ANTISENSE OLIGONUCLEOTIDES FOR TREATING A DISEASE OR CONDITION ASSOCIATED WITH AN ABNORMAL PROCESSING OF APP VICO THERAPEUTICS B.V. (NL) 2026-05-28 US disclosed
WO-2026099473-A1 OLIGONUCLEOTIDES WITH NEW INTERNUCLEOSIDE LINKAGE VICO THERAPEUTICS B.V. (NL) 2026-05-15 WO disclosed
US-20260115665-A1 ULTRAFILTRATION METHODS BioSpring Gesellschaft für Biotechnologie mbH (DE) 2026-04-30 US disclosed
US-4396556-A REACTING A 2-HALOACETAMIDE WITH A PHOSPHONATE, PHOSPHINATE, OR PHOSPHINE OXIDE IN A TWO-PHASE LIQUID SYSTEM OCCIDENTAL RESEARCH CORPORATION (US) 1983-08-02 US disclosed
US-4138432-A Amides of phosphonoacetic acid ABBOTT LABORATORIES (US) 1979-02-06 US disclosed
US-4087522-A Amides of phosphonoacetic acid for treating herpes simplex virus type 1 and 2 infections ABBOTT LABORATORIES (US) 1978-05-02 US disclosed